Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of the Aromatase Inhibitor Letrozole on Heart and Liver Function in Obese Men

NCT02097680 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT02097680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02097680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of the Aromatase Inhibitor Letrozole on Heart and Liver Function in Obese Men
Lead sponsor
University Hospital, Ghent
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2013
Completion date
June 30, 2015
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity